AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) is edging up in the morning session on Thursday.
As of 10:23, ACRX stock has gained 6.50% to $1.29. The stock has traded 549K shares, compared to its average volume of 2.47 million shares. The stock opened at $1.21 and moved in a range of $1.1900 – 1.2900.
ACRX Releases News Today
- ACRX announced an investigator-initiated study to be conducted at Tampa General Hospital to evaluate the use of DSUVIA for patients with sickle cell disease presenting to the emergency department (ED) with painful vaso-occlusive crisis (VOC).
- The study will enroll 100 patients presenting to the emergency department with VOC who are administered DSUVIA to manage the patients’ moderate-to-severe acute pain until an IV line can be accessed.
- The IV line is important for hydration, high-dose IV opioid administration as these patients are often opioid-tolerant, as well as administration of other parenteral medications.
|SHARES OUTSTANDING||119.10 M|
|SHARE FLOAT (%)||116.85 M (98.10%)|
|% HELD BY INSTITUTIONS||35.10|
Recent Stock Performance
|+/- EMA(20)||1.22 (+4.92%)|
|+/- SMA(50)||1.44 (-11.11%)|
|+/- SMA(200)||1.58 (-18.99%)|
|CCI20||88.7660||Buy||Chaikin Money Flow||0.1135||Buy|
|MACD||-0.0222||Sell||Money Flow Index||41.4044||Sell|
|STOCH (14,3)||100.0000||OverBought||STOCH RSI||1.0000||OverBought|